Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX was delisted on the 23rd of January, 2024.
37 hedge funds and large institutions have $765M invested in Orchard Therapeutics plc American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$304M |
| 2 |
DM
Deerfield Management
New York
|
+$120M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$72.2M |
| 4 |
CI
Cowen Inc
New York
|
+$43.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$28.5M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DIM
26
DC Investments Management
Mclean,
Virginia
| $674K | +$639K | +4,286 | New |
|
27
TD Asset Management
Toronto,
Ontario, Canada
| $657K | +$622K | +4,175 | New |
|
28
Norges Bank
Oslo,
Norway
| $629K | +$596K | +4,000 | New |
|
29
Northern Trust
Chicago,
Illinois
| $579K | +$549K | +3,681 | New |
|
|
PPA
30
Parametric Portfolio Associates
Seattle,
Washington
| $510K | +$483K | +3,242 | New |
|
|
CS
31
Credit Suisse
Zurich,
Switzerland
| $179K | +$169K | +1,135 | New |
|
32
Morgan Stanley
New York
| $136K | +$129K | +863 | New |
|
33
Victory Capital Management
San Antonio,
Texas
| $106K | +$100K | +672 | New |
|
|
KSCM
34
Kamunting Street Capital Management
Miami Beach,
Florida
| $48K | +$45.5K | +305 | New |
|
35
UBS Group
Zurich,
Switzerland
| $19K | +$18.5K | +124 | New |
|
|
CCA
36
Catalyst Capital Advisors
Huntington,
New York
| $7K | +$6.86K | +46 | New |
|
37
Barclays
London,
United Kingdom
| $2K | +$1.49K | +10 | New |
|
ORTX Hedge Fund Activity: Q4 2018 in Review
37 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q4 2018, worth a combined $765M.
Buyers outnumbered sellers: 37 funds opened new ORTX positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $304M.
- 37 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q4 2018, up from 0 in Q3 2018.
- Funds reported $765M of Orchard Therapeutics plc American Depositary Shares stock for Q4 2018.
- 37 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q4 2018 and 0 closed out, a net change of +37 holders.
- The largest Orchard Therapeutics plc American Depositary Shares buyer in Q4 2018 was Fidelity Investments, an estimated $304M added.
Based on aggregated 13F filings for Q4 2018.